Akihito Nagata
Overview
Explore the profile of Akihito Nagata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaito S, Najima Y, Sadato D, Hirama C, Kishida Y, Nagata A, et al.
Bone Marrow Transplant
. 2024 May;
59(8):1169-1175.
PMID: 38783125
Disease recurrence remains the principal cause of treatment failure after allogeneic hematopoietic stem cell transplantation. Post-transplant maintenance therapy with azacitidine (AZA) is promising to prevent relapse but the outcomes are...
2.
Konishi T, Sadato D, Toya T, Hirama C, Kishida Y, Nagata A, et al.
Sci Rep
. 2023 Feb;
13(1):2641.
PMID: 36788335
Young adults with myelodysplastic syndrome (MDS) are rare, and the clinical significance of driver mutations has not yet been analysed. We analysed the gene mutations and copy number alterations (CNAs)...
3.
Konishi T, Ogawa H, Najima Y, Hashimoto S, Kito S, Atsuta Y, et al.
Ann Med
. 2022 Oct;
54(1):2616-2625.
PMID: 36254468
Background And Objectives: Intensity-modulated radiation therapy (IMRT) helps achieve good radiation dose conformity and precise dose evaluation. We conducted a single-centre prospective study to assess the safety and feasibility of...
4.
Nagata A, Otsuka Y, Konuma R, Adachi H, Wada A, Kishida Y, et al.
Leuk Lymphoma
. 2022 Sep;
63(13):3117-3127.
PMID: 36067521
Sarcopenia is a prognostic factor for cancer. Because creatinine is formed from creatine phosphate in muscle tissue, urinary creatinine excretion (UCE) serves as an index of muscle volume. However, as...
5.
Shirane S, Najima Y, Fukushima K, Sekiya N, Funata N, Kishida Y, et al.
J Infect Chemother
. 2022 Aug;
28(12):1658-1662.
PMID: 35963603
Invasive mucormycosis is a refractory fungal infection. Central nervous system (CNS) mucormycosis is a rare complication caused by infiltration from the paranasal sinuses or hematogenous dissemination. Here, we present a...
6.
Tsushima T, Sato N, Guo Y, Uchiyama S, Nakamura H, Nagata A, et al.
Ann Hematol
. 2022 Mar;
101(7):1603-1605.
PMID: 35325305
No abstract available.
7.
Marumo A, Omori I, Tara S, Otsuka Y, Konuma R, Adachi H, et al.
Asia Pac J Clin Oncol
. 2022 Mar;
18(5):e507-e514.
PMID: 35289086
Cyclophosphamide (CY)-induced cardiotoxicity involves rare lethal complications. We previously reported the cardiac events of 811 allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients; 12 out of 811 recipients (1.5%) developed fatal...
8.
Wada A, Doki N, Otsuka Y, Adachi H, Konuma R, Kishida Y, et al.
Rinsho Ketsueki
. 2022 Mar;
63(2):104-107.
PMID: 35264498
Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However,...
9.
Yamada Y, Konishi T, Nagata A, Toya T, Najima Y, Kobayashi T, et al.
Int J Hematol
. 2022 Jan;
115(3):449-451.
PMID: 35066800
No abstract available.
10.
Yamada Y, Ikegawa S, Najima Y, Atsuta Y, Konuma R, Adachi H, et al.
Int J Hematol
. 2021 Oct;
115(2):244-254.
PMID: 34652634
Fludarabine with intravenous busulfan (6.4 mg/kg; FB2) and fludarabine with intermediate-dose melphalan (140 mg/m; FM140) are the most widely used reduced-intensity conditioning (RIC) regimens for allogeneic hematopoietic stem cell transplantation....